About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials | 7,493 Studies Recruiting

Clinical TrialsProstate Cancer

Prostate Cancer Clinical Trials

Browse 7,493 clinical trials for prostate cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1501-1520 of 7,493 trials

CompletedChemotherapy in Treating Patients With Solid TumorsRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00003103·New York, New York CompletedA Study to Compare the Effect of ASP3550 With Goserelin in Patients With Prostate CancerTo compare the efficacy and safety of ASP3550 to goserelin acetate in patients with prostate cancer.NCT01964170·Chugoku and 7 others RecruitingPRospective Observational Study of STereotactic Body rAdiation Therapy With Androgen Deprivation Therapy for Organ-confined High-risk Prostate Cancer: the PROSTAR TrialProstate Cancer (PCa) is the second most common malignancy and the 5th common cause of cancer-related mortality in men worldwide.NCT06949254·Bergamo, Bergamo and 2 others

Related Searches

prostate carcinomatrials

Data from ClinicalTrials.govTerms

CompletedPositron Emission Tomography and Magnetic Resonance Imaging for Prostate CancerBackground: * Prostate cancers are difficult to see on most imaging studies such as X-rays, computed tomography (CT) scans, conventional magnetic resonance imaging (MRI) scans…NCT00924313·Bethesda, Maryland

RecruitingTesting the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary TumorsThis phase II trial studies how well cabozantinib works in combination with nivolumab and ipilimumab in treating patients with rare genitourinary (GU) tumors that has spread from…NCT03866382·Birmingham, Alabama and 580 others

TerminatedDose Escalation and Dose Expansion Study of CPO-100 in Patients With Advanced Solid TumorsThis is a Phase 1, multicenter, open-label, dose escalation and dose expansion study to evaluate the safety, tolerability, pharmacokinetics, and preliminary evidence of antitumor…NCT04931823·Los Angeles, California and 7 others

CompletedSoy Isoflavones in Treating Patients Who Are Undergoing Radical Prostatectomy for Stage I or Stage II Adenocarcinoma of the ProstateRATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent or delay the development of early cancer.NCT00078923·Detroit, Michigan

CompletedAdjuvant Leuprolide With or Without Docetaxel in High Risk Prostate Cancer After Radical ProstatectomyThis is a prospective, multicenter, open-label, randomized phase III study in participants at high risk of recurrent prostate cancer after radical prostatectomy.NCT00283062·Bridgewater, New Jersey and 16 others

CompletedApatinib in Combination With Stereotactic Body Radiation Therapy (SBRT) Treatment for Symptomatic Metastatic Prostate CancerTo study safety and efficacy of apatinib in combination of radiotherapy in patients with symptomatic bony disease prostate cancer (SBPC), based on the potential synergistic…NCT02998242

CompletedProstate Cancer Intensive, Non-Cross Reactive Therapy (PRINT) for Castration Resistant Prostate Cancer (CRPC)The purpose of this study is to determine the clinical benefits of using a rapidly cycling, non-cross reactive regimen of FDA-approved prostate cancer therapeutic agents in the…NCT02903160·New York, New York and 1 other

TerminatedHealth Literacy in Understanding Radiation Therapy Information in Patients Undergoing Definitive Radiation TherapyThis study assesses the health literacy and understanding of radiation therapy information during consultation in patients with prostate or breast cancer undergoing definitive…NCT04927559·Los Angeles, California

UnknownPhase 1-2 Study of Onapristone in Patients With Advanced Castration-resistant Prostate CancerThis is an open-label, randomized, parallel group two-stage phase 1-2 study with an escalation and an expansion component.NCT02049190·Sutton Surrey

CompletedHormone Therapy and Radiation Therapy or Hormone Therapy and Radiation Therapy Followed by Docetaxel and Prednisone in Treating Patients With Localized Prostate CancerRATIONALE: Androgens can cause the growth of prostate cancer cells.NCT00288080·Birmingham, Alabama and 253 others

RecruitingA Phase Ib/II Open-label Study of AMO959 With Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in Combination With ARPI in Adult Participants With PSMA-positive mCRPCThe purpose of this phase Ib/II study is to (a) in Phase Ib evaluate the safety, tolerability, and pharmacokinetics (PK) of AMO959 when given in combination with lutetium (177Lu)…NCT07226986·Los Angeles, California and 22 others

CompletedAZD0530 in Treating Patients With Prostate Cancer That Did Not Respond to Hormone TherapyThis phase II trial is studying how well AZD0530 works in treating patients with prostate cancer that did not respond to hormone therapy.NCT00513071·Duarte, California

UnknownQuality of Life Study for Prostate Cancer PatientsThe goal of this behavioral research study is to look at patients' quality of life after treatment or management for prostate cancer.NCT00561444·Voorhees Township, New Jersey and 2 others

CompletedTaste Acceptability of Tomato-Soy-Arugula Seed Beverages in Men With Prostate CancerThis study is a sensory analysis of several different formulations of a novel tomato-soy-arugula seed beverage in men with prostate cancer.NCT02927899·Columbus, Ohio

RecruitingCharacterizing the Genomic Landscape of Prostate Cancer in Native American Populations (NAT-Geno)The purpose of this study is to analyze tumor tissue samples from patients of Native American identity with prostate cancer.NCT06960798·Oklahoma City, Oklahoma

CompletedStudy of ADXS-504 Immunotherapy for Recurrent Prostate CancerPrimary Objective: \- To evaluate the safety and tolerability of ADXS-504 and to determine the MTD (maximum tolerated dose) or RP2D (recommended phase two dose) Secondary…NCT05077098·New York, New York

Active not recruitingRadiation Therapy in Treating Patients Receiving Hormone Therapy for Prostate Cancer (GETUG-AFU 18)RATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells.NCT00967863·Angers and 24 others

PreviousPage 76 of 375Next